Institut Virion\serion Gmbh Pharmaceutical Import Profile — Germany (DGFT 2022–2026)

Name: Institut Virion\serion Gmbh Pharmaceutical Import Records from India — 2 Products, $300.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Institut Virion\serion Gmbh — Pharmaceutical Importer Profile (2026) | 2 Products, $300.0K Trade | TransData Nexus

Institut Virion\serion Gmbh — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Institut Virion\serion GmbH is a German pharmaceutical importer specializing in the acquisition and distribution of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Headquartered in Germany, the company plays a pivotal role in the nation's pharmaceutical supply chain by sourcing and supplying a diverse range of medical products to various healthcare providers. As a key player in Germany's pharmaceutical distribution network, Institut Virion\serion GmbH ensures the availability of essential medications to meet the needs of the German healthcare system.

The company's operations are characterized by a strategic focus on sourcing high-quality pharmaceutical products from international markets, particularly India. This approach enables Institut Virion\serion GmbH to offer a comprehensive portfolio of medications that cater to a wide array of therapeutic areas. By leveraging its expertise in international procurement and distribution, the company contributes significantly to the efficiency and effectiveness of Germany's healthcare delivery.

2Distribution Network

Institut Virion\serion GmbH maintains a robust distribution network within Germany, encompassing strategically located warehouses and advanced logistics capabilities. These facilities are designed to ensure the timely and efficient delivery of pharmaceutical products across the country. The company's geographic coverage extends beyond Germany, facilitating the export of medical products to neighboring European markets, thereby enhancing its regional presence and influence in the pharmaceutical sector.

The logistics infrastructure of Institut Virion\serion GmbH is optimized for the handling of pharmaceutical goods, adhering to stringent regulatory standards to maintain product integrity and compliance. This comprehensive distribution network underscores the company's commitment to meeting the diverse needs of healthcare providers and patients, both domestically and internationally.

3Industry Role

Institut Virion\serion GmbH operates as a primary wholesaler in Germany's pharmaceutical supply chain. By importing finished pharmaceutical formulations from international markets, particularly India, the company serves as a critical intermediary between global manufacturers and local healthcare providers. This role involves the procurement, storage, and distribution of a wide range of medical products, ensuring their availability to hospitals, clinics, pharmacies, and other healthcare institutions across Germany.

The company's position as a wholesaler enables it to leverage economies of scale, negotiate favorable terms with suppliers, and offer competitive pricing to its customers. This strategic role is essential in maintaining the efficiency and effectiveness of Germany's healthcare system, as it ensures a steady and reliable supply of necessary medications to meet patient needs.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Institut Virion\serion Gmbh

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Institut Virion\serion GmbH's sourcing strategy exhibits a notable concentration on imports from India, with a total import value of $300,000 USD across six shipments. This focus on a single source country indicates a strategic choice to leverage India's established pharmaceutical manufacturing capabilities and cost advantages. The company's portfolio concentration, with the top five products accounting for 100% of imports, suggests a targeted approach to meet specific market demands.

While this sourcing strategy offers potential benefits such as cost efficiency and streamlined supply chain management, it also presents risks associated with single-source dependency. Any disruptions in India's pharmaceutical production or export processes could impact Institut Virion\serion GmbH's ability to fulfill its obligations to German healthcare providers. To mitigate these risks, the company may consider diversifying its supplier base and exploring alternative sourcing options to enhance supply chain resilience.

2Supply Chain Resilience

Institut Virion\serion GmbH's reliance on Indian suppliers for its pharmaceutical imports necessitates a thorough assessment of supply chain resilience. The company must evaluate the stability and reliability of its Indian suppliers, considering factors such as production capacity, adherence to international quality standards, and compliance with regulatory requirements. Establishing robust relationships with multiple suppliers can provide a buffer against potential disruptions and ensure a continuous supply of products.

Importing Pharmaceuticals into Germany — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Germany

1Regulatory Authority & Framework

In Germany, the primary regulatory authority overseeing pharmaceutical imports is the Federal Institute for Drugs and Medical Devices (BfArM). BfArM is responsible for ensuring the safety, efficacy, and quality of pharmaceutical products available in the German market. The key legislation governing pharmaceutical imports includes the German Medicines Act (AMG), which outlines the requirements for marketing authorization, importation, and distribution of medicinal products.

For Indian generics to be marketed in Germany, they must undergo a marketing authorization process, which can be achieved through the centralized procedure via the European Medicines Agency (EMA) or the decentralized procedure involving national authorities. This process ensures that imported generics meet the stringent standards set by European regulators, facilitating their entry into the German market.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products in Germany are stringent, necessitating that all imported medicines possess a valid marketing authorization. This authorization confirms that the product has been evaluated and approved by the relevant regulatory authorities, ensuring its safety and efficacy. Additionally, the Good Manufacturing Practice (GMP) certification of the manufacturing facility is a critical component of the import process.

Institut Virion\serion Gmbh — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Institut Virion\serion GmbH's product category focus on medical devices and diagnostics, with a portfolio concentration of 100% in this area, reflects a strategic decision to cater to the growing demand for diagnostic tools and medical devices in Germany. The company's imports from India, totaling $300,000 USD across six shipments, underscore the importance of these product categories in its overall sourcing strategy.

The market demand for diagnostic products is driven by advancements in medical technology, an aging population, and an increased emphasis on preventive healthcare. By focusing on these therapeutic areas, Institut Virion\serion GmbH positions itself to meet the evolving needs of the German healthcare system, ensuring the availability of essential diagnostic tools and medical devices to healthcare providers and patients.

2Sourcing Profile

Institut Virion\serion GmbH's sourcing strategy emphasizes the procurement of finished pharmaceutical formulations from India, particularly in the medical devices and diagnostics category. This approach leverages India's established pharmaceutical manufacturing capabilities and cost advantages, enabling the company to offer a diverse range of high-quality products to the German market.

The company's sourcing profile indicates a preference for suppliers that adhere to international quality standards and possess valid GMP certifications from recognized bodies such as the EU, WHO, and PIC/S. This focus ensures that imported products meet the stringent regulatory requirements of the German market, maintaining the company's reputation for quality and reliability.

Seller's Guide — How to Become a Supplier to Institut Virion\serion Gmbh

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the German market through Institut Virion\serion GmbH. The company's focus on medical devices and diagnostics, with a portfolio concentration of 100% in this category, indicates a sustained demand for these products. Indian exporters can capitalize on this opportunity by ensuring compliance with German regulatory standards, obtaining necessary certifications, and demonstrating product quality and reliability.

Potential gaps in Institut Virion\serion GmbH's current sourcing include the need for diversification in product offerings and the exploration of alternative suppliers to mitigate risks associated with single-source dependency. Indian exporters can address these gaps by offering a broader range of products and establishing robust supply chain relationships to enhance resilience.

2Requirements & Qualifications

Indian exporters seeking to supply Institut Virion\serion GmbH and the German market must meet several requirements and qualifications. These include obtaining valid marketing authorization for their products, ensuring that manufacturing facilities hold GMP certifications recognized by the EU, WHO, or PIC/S, and complying with German labeling and serialization mandates.

Additionally, exporters must adhere to import licensing requirements and be prepared to undergo batch testing and stability studies to verify product quality. Establishing a strong understanding of the German regulatory framework and maintaining open communication with Institut Virion\serion GmbH are essential steps in meeting these requirements.

Frequently Asked Questions — Institut Virion\serion Gmbh

What products does Institut Virion\serion Gmbh import from India?

Institut Virion\serion Gmbh imports 2 pharmaceutical products across 1 categories. Top imports: Diagnostic ($150.0K), Reagent ($150.0K).

What is Institut Virion\serion Gmbh's total pharmaceutical import value?

Institut Virion\serion Gmbh's total pharmaceutical import value from India is $300.0K, based on 6 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Institut Virion\serion Gmbh focus on?

Institut Virion\serion Gmbh imports across 1 categories. The largest: Medical Devices & Diagnostics (100.0%).

Get Full Institut Virion\serion Gmbh Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

#	Product	Category	Value	Ships	Share	Rk
1	Diagnostic	Medical Devices & Diagnostics	$150.0K	3	0.8%	6
2	Reagent	Medical Devices & Diagnostics	$150.0K	3	1.1%	4

Institut Virion\serion Gmbh

Institut Virion\serion Gmbh — Import Portfolio & Supplier Network

What Products Does Institut Virion\serion Gmbh Import?

Top Products by Import Value

Institut Virion\serion Gmbh Therapeutic Categories — 1 Specializations

Import Portfolio — Top 2 by Import Value

Key Metrics

Top Categories

Related Trade Data

Need Detailed Data?